Aurobindo Pharma Ltd. Investor Presentation

Aurobindo Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Aurobindo Pharma Ltd.
13 Feb 2017
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
15 Nov 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
14 Nov 2016
1106.50
0.99%
Investors Presentation
BSE India
Aurobindo Pharma Ltd has informed BSE about Investor Presentation for the period ended September 30, 2016
pdf
logo
Aurobindo Pharma Ltd.
14 Sep 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
07 Sep 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
29 Aug 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
23 Aug 2016
1106.50
0.99%
Investors/Analysts Presentation
BSE India
Aurobindo Pharma Ltd has submitted to BSE a copy of the presentation to the Investors/Analysts on the Unaudited Financial Results of the Company for the first quarter ended June 30, 2016.
pdf
logo
Aurobindo Pharma Ltd.
01 Jun 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
12 Feb 2016
1106.50
0.99%
pdf
logo
Aurobindo Pharma Ltd.
13 Jan 2016
1106.50
0.99%
Investor Presentation
BSE India
Aurobindo Pharma Ltd has submitted to BSE a copy of Investor Presentation.
pdf